Stay updated on Nivolumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; minor platform update.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the Notice about a lapse in government funding and operating status, and deleted Revision: v3.4.1.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedMinor UI/text updates on the study page include adding a glossary option and updating/adding labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older terms 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor metadata change with no impact on page content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations section added, listing all participating states for trial sites. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to Nivolumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.